ATE138565T1 - Galenische 2-beta-mimetik-formen für die per- und sublinguale verabreichung - Google Patents

Galenische 2-beta-mimetik-formen für die per- und sublinguale verabreichung

Info

Publication number
ATE138565T1
ATE138565T1 AT88420298T AT88420298T ATE138565T1 AT E138565 T1 ATE138565 T1 AT E138565T1 AT 88420298 T AT88420298 T AT 88420298T AT 88420298 T AT88420298 T AT 88420298T AT E138565 T1 ATE138565 T1 AT E138565T1
Authority
AT
Austria
Prior art keywords
impregnation
per
subdilutions
beta2
mimetic
Prior art date
Application number
AT88420298T
Other languages
English (en)
Inventor
Clairet Josiane Ayache
Jean-Jacques Ayache
Georges Bruttmann
Patrick Pedrali
Serge Robert
Original Assignee
Medibrevex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibrevex filed Critical Medibrevex
Application granted granted Critical
Publication of ATE138565T1 publication Critical patent/ATE138565T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88420298T 1987-09-02 1988-09-01 Galenische 2-beta-mimetik-formen für die per- und sublinguale verabreichung ATE138565T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712708A FR2619718B1 (fr) 1987-09-02 1987-09-02 Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale

Publications (1)

Publication Number Publication Date
ATE138565T1 true ATE138565T1 (de) 1996-06-15

Family

ID=9354872

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88420298T ATE138565T1 (de) 1987-09-02 1988-09-01 Galenische 2-beta-mimetik-formen für die per- und sublinguale verabreichung

Country Status (9)

Country Link
US (1) US5080903A (de)
EP (1) EP0306422B1 (de)
JP (1) JP2716155B2 (de)
AT (1) ATE138565T1 (de)
CA (1) CA1328621C (de)
DE (1) DE3855323T2 (de)
ES (1) ES2087855T3 (de)
FR (1) FR2619718B1 (de)
GR (1) GR3020722T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
JP2909678B2 (ja) * 1991-03-11 1999-06-23 レール・リキード・ソシエテ・アノニム・プール・レテュード・エ・レクスプロワタシオン・デ・プロセデ・ジョルジュ・クロード 圧力下のガス状酸素の製造方法及び製造装置
FR2720276B1 (fr) * 1994-05-24 1997-09-05 Christophe Boyer Nouvelle utilisation thérapeutique des agents bétamimétiques et médicament en contenant.
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
WO1997019680A1 (fr) * 1995-11-28 1997-06-05 Christophe Boyer Utilisation therapeutique d'agents betamimetiques pour traiter les douleurs menstruelles par voie permuqueuse
WO1998018827A1 (en) * 1996-10-28 1998-05-07 Farmarc Nederland B.V. Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
WO1999040898A2 (en) * 1998-02-12 1999-08-19 Centrapharm Inc. Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9289583B2 (en) * 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
AU2007302256A1 (en) * 2006-09-27 2008-04-03 Niconovum Ab Directional use
ES2534433T3 (es) * 2007-08-07 2015-04-22 Acelrx Pharmaceuticals, Inc. Composiciones que comprenden sufentanilo y triazolam para sedación y analgesia operatorias utilizando formas farmacéuticas transmucosas orales
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
EP2910240B1 (de) * 2014-02-25 2021-07-07 Biologische Heilmittel Heel GmbH Methode zur Herstellung von Globuli

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH156609A (de) * 1931-01-27 1932-08-15 Chem Pharm Lab Bika V Poehlman Verfahren zur Herstellung eines trockenen, homöopathischen Heilmittels.
US3975391A (en) * 1973-12-26 1976-08-17 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US5080903A (en) 1992-01-14
EP0306422B1 (de) 1996-05-29
CA1328621C (fr) 1994-04-19
GR3020722T3 (en) 1996-11-30
DE3855323T2 (de) 1996-10-10
FR2619718A1 (fr) 1989-03-03
JP2716155B2 (ja) 1998-02-18
EP0306422A1 (de) 1989-03-08
FR2619718B1 (fr) 1991-07-12
ES2087855T3 (es) 1996-08-01
DE3855323D1 (de) 1996-07-04
JPH01100117A (ja) 1989-04-18

Similar Documents

Publication Publication Date Title
DE3855323D1 (de) Galenische 2-beta-Mimetik-Formen für die per- und sublinguale Verabreichung
NL300277I1 (nl) Galenische vormen van allergenen voor sublinguale toediening.
DE10199027I1 (de) Fluorcytidinderivate deren Herstellung und Arzneimittel die diese Derivate enthalten
DE3688031D1 (de) Galenische formen des verapamils, deren herstellung sowie diese enthaltende arzneimittel.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO912142D0 (no) Foradditiv for fisk.
FI884660A (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
NL171270C (nl) Werkwijze voor de bereiding van 1,2,3,4,6,7,12,12a-octahydropyrazinoŸ2',1':6,1Ÿ pyridoŸ3,4-bŸindolen en werkwijze voor de bereiding van preparaten die ze bevatten.
DE3887066T2 (de) Galenische Kortikoidformen für die per- und sublinguale Verabreichung und ihr Herstellungsverfahren.
ATE114245T1 (de) Galenische formen von gammaglobulinen für die sublinguale verabreichung.
ATE103907T1 (de) Cyclopropyl-substituierte azolylmethylcarbinole, verfarhren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE55985T1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
ES2043722T3 (es) Formulacion oral de teofilina de liberacion sostenida en seco y mejorada.
ATE108336T1 (de) Galenische formen von antiinflammatorischen gammaglobulinen für die sublinguale verabreichung.
PT86623A (pt) Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles
NL7701695A (nl) Werkwijze voor de bereiding van 2.2-dimethyl- -3-(2'.2'-dichloorvinyl) cyclopropaan-1-carbon- zuur.
NL7901103A (nl) 1,1-digesubstitueerde octahydroindool 2,3-a chinoli- zinen, farmaceutisch aanvaardbare zouten daarvan; werk- wijze voor de bereiding van deze verbindingen, farmaceutische preparaten waarin zich deze verbindingen bevinden, met vaatverwijdende eigenschappen.
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
NO154427C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte hexahydro-pyrimido (1,2-a) azepiner.
IT7950828A0 (it) Procedimento per la preparazione di 1,2,4,5-tetraidro-7-alcossi-(e 7,8dialcossi)-3h,3-benzazepine e loro derivati 3-sostituiti dalle corrispondenti fenetilammine
HUT63329A (en) Process for producing pharmaceutical compositions comprising 3-aryl-1,2,4-triazole derivatives as active ingredient
ATE81343T1 (de) Pyrimidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties